Shanghai - Delayed Quote CNY

FOSUN PHARM (600196.SS)

23.81

+0.15

+(0.63%)

At close: January 24 at 3:00:07 PM GMT+8

Fosun Pharma Announces 2024Q3 Financial Results

On October 29, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its operating performance for the first three quarters of 2024. From January to September 2024, Fosun Pharma achieved revenue of RMB30.91 billion, an increase of about 5.74% YoY after excluding COVID-related products. The net profit attributable to owners of the parent of the Group after deducting extraordinary gain or loss amounted to RMB1.84 billion, up by

PR Newswire 2 months ago

SFOSF
Fosun Pharma Announces 2024 Interim Results

On August 27, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its operating performance for the first half of 2024 (the "Reporting Period"). During the Reporting Period, Fosun Pharma achieved revenue of RMB20.46 billion, an increase of 5.31% YoY after excluding COVID-related products. The net profit attributable to owners of the parent of the Group after deducting extraordinary gain or loss amounted to RMB1.3 billion. In

PR Newswire 4 months ago

SFOSF
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world. WHO stated that malaria not only continues to directly endanger health and cost lives, but it also perpetuates a vicious cycle of inequity. People living in the most vulnerable situations including pregnant women and children under 5 years of age continue to be disproportionately impacted.

PR Newswire 8 months ago

SFOSF

Performance Overview

Return	600196.SS	SSE Composite Index
YTD	-5.81%	-4.54%
1-Year	+7.24%	+17.38%
3-Year	-51.87%	-7.66%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

FOSUN PHARM (600196.SS)

Fosun Pharma Announces 2024Q3 Financial Results

Fosun Pharma Announces 2024 Interim Results

Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

Performance Overview